Rocketing to a price of $106.75 during today's morning trading session, shares of BioNTech SE are still -23.88% below their ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sanofi (SNYNF – Research Report), Roche Holding AG (RHHVF – ...

Join us for a quick overview of BioNTech SE, a Biotechnology company whose shares moved 0.3% today. Here are some facts about ...

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on BioNTech SE (BNTX – Research Report). The ...